Memorial Sloan Kettering is closely monitoring the COVID-19 outbreak. We continue to provide our patients with the best cancer care, and the health and safety of our patients and staff is always our top priority. We are taking proactive steps to ensure the continued safety and wellbeing of our community. More information on MSK’s response to COVID-19 is available here. If you have any questions, please contact us.
Together We Fight
Thank you riders and donors!
$40,003,393
2020 Fundraising Total
Search for a team member
Search for a team
2020 Top Teams
#1
$703,374.00
Gold Ribbon Riders
#2
$500,000.00
JPMC
#3
$253,540.00
Team Perry NYC
#4
$245,061.00
Team Rockstar - Bethesda
#5
$217,807.00
Team HOPP - Resnick
#6
$215,940.69
Team BEAM
#7
$187,962.45
MetLife Linda Markey
#8
$181,604.14
Team Suzi G
#9
$177,182.00
The Society of MSK
#10
$174,336.00
Team Dany Testa
2020 Top National Teams
#1
$1,097,698.38
JPMorgan Chase
#2
$746,918.00
Gold Ribbon Riders
#3
$624,549.99
Team HOPP
#4
$463,215.29
Blackstone National Team
#5
$418,492.00
Bank of America
#6
$369,169.00
Team Rockstar
#7
$364,481.14
Pedaling Sunshine
#8
$323,595.99
Team RBC
#9
$319,937.00
Team Perry
#10
$289,033.86
PerseVerance
Why We Ride
Rare cancer patients make up about half of all people fighting cancer, but they often have limited or no treatment options because rare cancer research is drastically underfunded.
Cycle for Survival raised $42 million in 2019—more than $260 million in over a decade. Every single dollar is directly allocated to rare cancer research at Memorial Sloan Kettering Cancer Center within six months of the close of fundraising.